Neoadjuvant nivolumab plus chemotherapy followed by resection for superior sulcus tumour with high PD‐L1 expression: A case report

Documenti analoghi

• Can FDG‐PET after neoadjuvant chemotherapy plus nivolumab predict residual disease in non‐small cell lung cancer?
  di: Hideto Iguchi, et al.
  Pubblicazione: (2024)
• Intra‐Tumoral Alveolar Remnants as a Prognostic Factor in Small Peripheral Lung Squamous Cell Carcinoma
  di: Hideto Iguchi, et al.
  Pubblicazione: (2025)
• Unsuccessful rechallenge with nivolumab in a patient with advanced non‐small cell lung cancer who had a 6‐year complete response and treatment‐free period: Case report
  di: Toshiaki Takakura, et al.
  Pubblicazione: (2024)
• Neoadjuvant chemotherapy for resectable gastric cancer is associated with better outcomes than neoadjuvant chemoradiation
  di: Hideo Takahashi, et al.
  Pubblicazione: (2024)
• Neoadjuvant tislelizumab plus pazopanib in renal cell carcinoma with venous tumour thrombus: A retrospective study
  di: Diliyaer Dilixiati, et al.
  Pubblicazione: (2025)